Keyphrases
Surgical Site Infection
100%
Colorectal Cancer
91%
Colorectal Surgery
84%
African American
65%
Hispanic
57%
Hazard Ratio
54%
Surgical Treatment
52%
Confidence Interval
51%
Safety-net Hospital
48%
Surgeons
43%
Cancer Survival Disparities
41%
C-Cbl
37%
Congenital Abdominal Wall Defect
37%
Rural Residency
37%
Patient Safety Outcomes
37%
Surgical Site Infection Prevention
37%
Bayesian Perspective
37%
Stoma Reversal
37%
Implicit Gender Bias
37%
Quality Improvement Study
37%
Perineal Rectosigmoidectomy
37%
Provider Perspectives
37%
Stage IV Colon Cancer
37%
Ostomates
37%
Hepatocellular Carcinoma
37%
Patient Perspective
37%
Antibiotic Prophylaxis
37%
Operative
37%
Transanal Total Mesorectal Excision (taTME)
37%
Texas Cancer Registry
37%
Associated Complications
37%
Multidisciplinary Treatment
37%
American Society
37%
Complication Risk
37%
Tumor Growth
37%
Academic Training
37%
Programmed Death-ligand 1 (PD-L1)
37%
Colon
37%
Comparative Effectiveness
37%
Female Representation
37%
Tripartite
37%
Laparoscopic Cholecystectomy
37%
Glycemic Control
37%
Component Separation
37%
Ketamine
37%
Right Time
37%
Patient Quality
37%
Educational Intervention
37%
Stoma Site
37%
Enhanced Recovery after Surgery (ERASĀ®)
37%
Medicine and Dentistry
Colorectal Surgery
84%
Surgery
66%
Quality Improvement
62%
Surgical Infection
61%
Hazard Ratio
54%
Rectum Cancer
53%
Stoma
46%
Surgeon
43%
Antibiotic Prophylaxis
37%
Breast Cancer Survival
37%
Proctopexy
37%
Hepatocellular Carcinoma
37%
Incisional Hernia
37%
Cancer Registry
37%
Total Mesorectal Excision
37%
Enhanced Recovery After Surgery
37%
Primary Tumor
37%
Colon
37%
Laparoscopic Cholecystectomy
37%
Cancer Surgery
37%
Patient Safety
37%
Digestive System Surgery
37%
Ketamine
37%
Rectal Prolapse
37%
Ileostomy
37%
Gender Bias
37%
Separation Technique
37%
Abdominal Wall Defect
37%
Colorectal Carcinoma
37%
Colon Carcinoma
37%
Proportional Hazards Model
25%
Opiate
25%
Meta-Analysis
25%
Malignant Neoplasm
23%
Postoperative Complication
21%
Odds Ratio
20%
Chemotherapy
17%
Disease
14%
Surgical Anastomosis
14%
Adjuvant Chemotherapy
14%
Neoplasm
13%
Metastatic Carcinoma
13%
Incision
12%
Analgesia
12%
Patient Population
12%
Adverse Event
12%
Mortality Rate
12%
Instrumental Variable Analysis
12%
Side Effect
12%
Antibiotics
12%